Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LABCORP HOLDINGS INC. Director's Dealing 2021

Feb 8, 2021

30237_dirs_2021-02-08_281b9b52-755f-4fc3-826b-30064e897494.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2021-02-04

Reporting Person: Wilkinson Peter J (SVP, Chief Accounting Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-04 Common Stock M 150 Acquired 576.2194 Direct
2021-02-04 Common Stock F 53 $223.78 Disposed 523.2194 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-02-04 Restricted Stock Unit $ M 150 Disposed Common Stock (150) Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: Amount includes 129.2194 shares acquired on June 30, 2020 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.

F3: Stock withholding to satisfy tax withholding obligations.

F4: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 4, 2021.

F5: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.